142 filings
Page 4 of 8
8-K
ead7zt9j79xp10skwjb
28 Sep 21
Other Events
4:05pm
8-K
3aky oj5q
9 Sep 21
Regulation FD Disclosure
6:13am
8-K
0mdxr
24 Aug 21
Other Events
9:07am
8-K
wx700dckjpxnif
5 Aug 21
Akebia Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Milestones
8:06am
8-K
u4ac 71ov
3 Jun 21
Submission of Matters to a Vote of Security Holders
8:01am
8-K
4gmh2aht1rtmcodab
1 Jun 21
Akebia and Otsuka Announce FDA Acceptance for Filing of New Drug Application for Vadadustat
6:08am
8-K
9rt86syt55x
10 May 21
Akebia Reports First Quarter 2021 Financial Results and Highlights Recent Company Milestones
8:11am
8-K
wta569jqsh82pc
30 Mar 21
Akebia Submits New Drug Application (NDA) to the FDA for Vadadustat for the Treatment of
9:07am
8-K
7ef b2rxv1
25 Feb 21
Akebia Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides
8:04am
8-K
rj8w08e5l2zwjo 849iz
18 Feb 21
Departure of Directors or Certain Officers
8:03am
8-K
yrwpwebg3bgm0bycn9w
17 Feb 21
Entry into a Material Definitive Agreement
4:06pm
8-K
2b3o8sa7ser9wlo
28 Jan 21
Departure of Directors or Certain Officers
4:29pm
8-K
80dp d0y2zk
12 Jan 21
Regulation FD Disclosure
7:06am
8-K
4oj8rt
15 Dec 20
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8:22am
8-K
rmyhaqdf11
2 Dec 20
Entry into a Material Definitive Agreement
4:17pm
8-K
xekq5q9ocdhm65jf2
5 Nov 20
Akebia Reports Third Quarter 2020 Financial Results and Recent Business Updates
8:15am
8-K
9w6l5brc3v
25 Sep 20
Other Events
8:16am
8-K
y890ap8jgbjyp3vk1132
11 Sep 20
Entry into a Material Definitive Agreement
5:00pm
8-K
9hp1jkf4h
3 Sep 20
Akebia Therapeutics Announces Top-Line Results from its PRO2TECT Global Phase 3 Program of
4:55pm
8-K
ptbsv88z
10 Aug 20
Akebia Reports Second Quarter 2020 Financial Results
4:02pm